Inicio > BIGG > Resultado de la búsqueda

    Resultados: 4

    GRADE: 15-valent pneumococcal conjugate vaccine (PCV15) use in children aged <2 years

    MMWR recomm. rep; 71 (37), 2022
    On June 22, 2022, ACIP recommended use of 15-valent pneumococcal conjugate vaccine (PCV15 [Vaxneuvance, Merck Sharp & Dohme LLC]) as an option for pneumococcal conjugate vaccination for persons aged <19 years according to currently recommended PCV13 dosing and schedules. A systematic review and Grading o...
    Infecciones Neumocócicas/inmunología, Vacuna Neumocócica Conjugada Heptavalente/uso terapéutico, Inmunogenicidad Vacunal
    Texto completo

    Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for Pneumococcal Vaccines for Adults aged ≥65 years

    MMWR recomm. rep; 63 (37), 2014
    GRADE was used to evaluate 13-valent Pneumococcal Conjugate Vaccine (PCV13) for routine use among adults aged ≥65 years. Evidence of benefits, harms, values and preferences, and cost-effectiveness were reviewed in accordance with GRADE methods.[1] The primary policy question was “Should PCV13 be adm...
    Vacunas Neumococicas/uso terapéutico, Infecciones Neumocócicas/inmunología, Vacunas Neumococicas/efectos adversos, Inmunogenicidad Vacunal
    Texto completo

    Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) of Pneumococcal Vaccines for Immunocompromised Children Aged 6 through 18 Years

    MMWR recomm. rep; 62 (25), 2013
    GRADE was used to evaluate 13-valent Pneumococcal Conjugate Vaccine (PCV13) for routine use among immunocompromised children aged 6 through 18 years. Evidence of benefits, harms, values and preferences, and cost-effectiveness were reviewed in accordance with GRADE methods.[1] The primary policy question...
    Vacunas Neumococicas/uso terapéutico, Huésped Inmunocomprometido, Infecciones Neumocócicas/inmunología, Anemia de Células Falciformes/inmunología, Infecciones por VIH/inmunología, Inmunogenicidad Vacunal
    Texto completo

    Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for Pneumococcal Vaccines for Immunocompromised Adults

    MMWR recomm. rep; 61 (40), 2012
    GRADE was used to evaluate 13-valent Pneumococcal Conjugate Vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPSV23) for routine use among immunocompromised adults. Evidence of benefits, harms, values and preferences, and cost-effectiveness were reviewed in accordance with GRADE methods...
    Vacunas Neumococicas/uso terapéutico, Infecciones Neumocócicas/inmunología, Huésped Inmunocomprometido, Inmunogenicidad Vacunal
    Texto completo